Literature DB >> 12933802

Determinants of binding affinity and specificity for the interaction of TEM-1 and SME-1 beta-lactamase with beta-lactamase inhibitory protein.

Zhen Zhang1, Timothy Palzkill.   

Abstract

The hydrolysis of beta-lactam antibiotics by class A beta-lactamases is a common cause of bacterial resistance to these agents. The beta-lactamase inhibitory protein (BLIP) is able to bind and inhibit several class A beta-lactamases, including TEM-1 beta-lactamase and SME-1 beta-lactamase. Although the TEM-1 and SME-1 enzymes share 33% amino acid sequence identity and a similar fold, they differ substantially in surface electrostatic properties and the conformation of a loop-helix region that BLIP binds. Alanine-scanning mutagenesis was performed to identify the residues on BLIP that contribute to its binding affinity for each of these enzymes. The results indicate that the sequence requirements for binding are similar for both enzymes with most of the binding free energy provided by two patches of aromatic residues on the surface of BLIP. Polar residues such as several serines in the interface do not make significant contributions to affinity for either enzyme. In addition, the specificity of binding is significantly altered by mutation of two charged residues, Glu73 and Lys74, that are buried in the structure of the TEM-1.BLIP complex as well as by residues located on two loops that insert into the active site pocket. Based on the results, a E73A/Y50A double mutant was constructed that exhibited a 220,000-fold change in binding specificity for the TEM-1 versus SME-1 enzymes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12933802     DOI: 10.1074/jbc.M308572200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Protein-protein binding affinities by pulse proteolysis: application to TEM-1/BLIP protein complexes.

Authors:  Melinda S Hanes; Kathleen Ratcliff; Susan Marqusee; Tracy M Handel
Journal:  Protein Sci       Date:  2010-10       Impact factor: 6.725

2.  Identification and characterization of beta-lactamase inhibitor protein-II (BLIP-II) interactions with beta-lactamases using phage display.

Authors:  N G Brown; T Palzkill
Journal:  Protein Eng Des Sel       Date:  2010-03-22       Impact factor: 1.650

3.  Computational redesign of the SHV-1 beta-lactamase/beta-lactamase inhibitor protein interface.

Authors:  Kimberly A Reynolds; Melinda S Hanes; Jodi M Thomson; Andrew J Antczak; James M Berger; Robert A Bonomo; Jack F Kirsch; Tracy M Handel
Journal:  J Mol Biol       Date:  2008-05-29       Impact factor: 5.469

4.  Analysis of the binding forces driving the tight interactions between beta-lactamase inhibitory protein-II (BLIP-II) and class A beta-lactamases.

Authors:  Nicholas G Brown; Dar-Chone Chow; Banumathi Sankaran; Peter Zwart; B V Venkataram Prasad; Timothy Palzkill
Journal:  J Biol Chem       Date:  2011-07-20       Impact factor: 5.157

5.  Use of periplasmic target protein capture for phage display engineering of tight-binding protein-protein interactions.

Authors:  Bartlomiej G Fryszczyn; Nicholas G Brown; Wanzhi Huang; Miriam A Balderas; Timothy Palzkill
Journal:  Protein Eng Des Sel       Date:  2011-09-06       Impact factor: 1.650

6.  BLIP-II Employs Differential Hotspot Residues To Bind Structurally Similar Staphylococcus aureus PBP2a and Class A β-Lactamases.

Authors:  Carolyn J Adamski; Timothy Palzkill
Journal:  Biochemistry       Date:  2017-02-16       Impact factor: 3.162

7.  BLIP-II is a highly potent inhibitor of Klebsiella pneumoniae carbapenemase (KPC-2).

Authors:  Nicholas G Brown; Dar-Chone Chow; Timothy Palzkill
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

8.  Identification of the β-lactamase inhibitor protein-II (BLIP-II) interface residues essential for binding affinity and specificity for class A β-lactamases.

Authors:  Nicholas G Brown; Dar-Chone Chow; Kevin E Ruprecht; Timothy Palzkill
Journal:  J Biol Chem       Date:  2013-04-27       Impact factor: 5.157

9.  Role of β-lactamase residues in a common interface for binding the structurally unrelated inhibitory proteins BLIP and BLIP-II.

Authors:  Bartlomiej G Fryszczyn; Carolyn J Adamski; Nicholas G Brown; Kacie Rice; Wanzhi Huang; Timothy Palzkill
Journal:  Protein Sci       Date:  2014-07-01       Impact factor: 6.725

10.  Engineering Specificity from Broad to Narrow: Design of a β-Lactamase Inhibitory Protein (BLIP) Variant That Exclusively Binds and Detects KPC β-Lactamase.

Authors:  Dar-Chone Chow; Kacie Rice; Wanzhi Huang; Robert L Atmar; Timothy Palzkill
Journal:  ACS Infect Dis       Date:  2016-10-26       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.